منابع مشابه
Challenges in translational research
We have seen, with some paternal pride, the first issue of EMBO Molecular Medicine (EMM). I am pleased to see the quality of the articles and the many lively sections of the journal; even more so because despite the excitement for this new initiative, I was slightly apprehensive about what seems to be a neverending proliferation of scientific journals. In the case of EMM, however, I feel that t...
متن کاملChallenges in translational research
We have seen, with some paternal pride, the first issue of EMBO Molecular Medicine (EMM). I am pleased to see the quality of the articles and the many lively sections of the journal; even more so because despite the excitement for this new initiative, I was slightly apprehensive about what seems to be a neverending proliferation of scientific journals. In the case of EMM, however, I feel that t...
متن کاملMechanisms and challenges in translational stroke research.
Translating basic science advances into clinical meaning has been challenging for stroke research. This does not, however, mean that the investigation of basic mechanisms is irrelevant. Translation is difficult because the underlying mechanisms are complex and ill-defined. The original focus on neuroprotection has now evolved into a broader consideration of the role of non-neuronal cells in str...
متن کاملGrand Challenges in Translational Materials Research
Technological progress in our modern society is driven by discovery and deployment of innovation in materials synthesis, design, and application. As such, research related to “Translational Materials,” which are capable of revolutionizing the growth of our civilization play pivotal roles. A key thrust, therefore, should be geared toward the development of novel, innovative, and practical soluti...
متن کاملTranslational research in primary mitochondrial diseases: challenges and opportunities.
On March 8–9, 2012, the NIH intramural and extramural research communities as well as representatives from industries and foundations with a common interest in primary mitochondrial diseases met in Bethesda to identify the major barriers to the development of better treatment for mitochondrial diseases. Besides the importance to the patient population, it has become clear in the last decade tha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: EMBO Molecular Medicine
سال: 2009
ISSN: 1757-4676,1757-4684
DOI: 10.1002/emmm.200900017